PubMed · 1990 · 22 citations · 3 references
MedicineClinical SciencesPharmacotherapyAntimicrobial PharmacologyGastroenterologyGastrointestinal PharmacotherapyGastric DiseasesGastric DisordersGastrointestinal InfectionsGastrointestinal InflammationGastrointestinal PharmacologyHelicobacter Pylori Eradication TherapyBismuth-based TherapyHelicobacter Pylori EradicationHelicobacter Pylori InfectionPlacebo Comparators
In a placebo controlled prospective clinical trial of bismuth salicylate in helicobacter pylori associated gastritis, 52 adult patients were randomly allocated to treatment with bismuth salicylate or placebo. Helicobacter pylori were totally cleared in 77% patients in bismuth group but none in placebo group (P less than 0.001). Resolution of gastritis (P less than 0.001) and improvement of symptoms (P less than 0.01) were significantly better in patients where H. pylori infection cleared as compared to patients where the infection persisted.
3
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
Y. Glupczynski, A Burette, M. Labbé et al. · PubMed · 1988 · 127 citations